Serum HSP-70 and XBP-1 as Diagnostic and Treatment- Monitoring Biomarkers in Breast Cancer
Introduction: To lower breast cancer mortality, clinicians need non-invasive biomarkers for earlier detection and evaluating disease status. HSP-70 controls protein folding and XBP-1 directs the unfolded protein response (UPR). Tumors exploit these dysregulated pathways for survival and drug resistance. We tested serum...